Evidence map›Paper›PMID 21225461›Full record

ArticlePrevention science : the official journal of the Society for Prevention Research2011

Corporate externalities: a challenge to the further success of prevention science.

Anthony Biglan

Abstract read
In one paragraph

Article in Prevention science : the official journal of the Society for Prevention Research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. The Ultimate Goal of Prevention and the Larger Context for Translation.Prevention science : the official journal of the Society for Prevention Research · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. A Framework for Intentional Cultural Change.Journal of contextual behavioral science · 2013
    Article
  11. Integrating the Human Sciences to Evolve Effective Policies.Journal of economic behavior & organization · 2013
    Article
  12. Evolving prosocial and sustainable neighborhoods and communities.Annual review of clinical psychology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Anthony BiglanCenter on Early Adolescence, Oregon Research Institute, 1715 Franklin Boulevard, Eugene, OR 97403-1983, USA. tony@ori.org

Funding

MOBILIZING PARENTS AND PEERS TO PREVENT TOBACCO USER01CA038273 · NCI · OREGON RESEARCH INSTITUTE · PI BIGLAN, ANTHONY · 1985 to 2004
$5.2M
CORE--METHODOLOGYP30DA018760 · NIDA · OREGON RESEARCH INSTITUTE · PI BIGLAN, ANTHONY · 2005 to 2009
$3.4M
Creating the Scientific Infrastructure for the Promise Neighborhood InitiativeRC2DA028946 · NIDA · OREGON RESEARCH INSTITUTE · PI BIGLAN, ANTHONY, FLAY, BRIAN R. · 2009 to 2010
$3.4M
NCI NIH HHS CA-38273NCI NIH HHS R01 CA038273NIDA NIH HHS P30 DA018760NIDA NIH HHS RC2 DA028946
6 · The paper itself

Abstract

The full benefit of prevention science will not be realized until we learn how to influence organizational practices. The marketing of tobacco, alcohol, and food and corporate advocacy for economic policies that maintain family poverty are examples of practices we must influence. This paper analyzes the evolution of such practices in terms of their selection by economic consequences. A strategy for addressing these critical risk factors should include: (a) systematic research on the impact of corporate practices on each of the most common and costly psychological and behavior problems; (b) empirical analyses of the consequences that select harmful corporate practices; (c) assessment of the impact of policies that could affect problematic corporate practices; and (d) research on advocacy organizations to understand the factors that influence their growth and to help them develop effective strategies for influencing corporate externalities.

Indexed as

Preventive Health ServicesHumansMarketing

Identifiers

PMID21225461
PMCPMC3042055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.